THE WHAT? Clarins has announced its new governance structure, which formalizes the handover of the company from the second to the third generation.
THE DETAILS Virginie and Prisca Courtin will guide Clarins, looking to continue growing the company ‘in line with its current strategy.’
Virginie Courtin has been appointed Managing Director, alongside President & CEO Jonathan Zrihen and her uncle, Olivier Courtin, who is also Managing Director. Courtin has served as Deputy CEO since 2018.
Prisca Courtin has become Chairman of the Supervisory Board, which monitors the company’s strategic orientations. She has been a member of the Supervisory Board since 2018. Courtin will replace her Uncle, Christian Courtin.
Clarins Board of Directors includes Jonathan Zrihen, President & CEO, Olivier Courtin, Managing Director, and Virginie Courtin, Managing Director.
Meanwhile the Supervisory Board comprises Prisca Courtin, Chairman, Guillaume de Malliard, Vice-Chairman, Michel Cohen and Virginie Verin.
THE WHY? Jonathan Zrihen, President & CEO of Clarins, said, “These appointments embody the company’s commitment to change within a framework of continuity. With Virginie and Prisca taking the helm of the company, we will continue to work together to write the next chapter in Clarins’s incredibly story while pursuing our strategic Clarins Unlimited plan, which aims to focus on our brands, well-being and health.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
